Aberrant expression of SETD1A promotes survival and migration of estrogen receptor alpha-positive breast cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, Ming Li | - |
dc.contributor.author | Kim, Young Woong | - |
dc.contributor.author | Jin, Hong Lan | - |
dc.contributor.author | Kang, Hoin | - |
dc.contributor.author | Lee, Eun Kyung | - |
dc.contributor.author | Stallcup, Michael R. | - |
dc.contributor.author | Jeong, Kwang Won | - |
dc.date.available | 2020-02-27T08:41:07Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-12-01 | - |
dc.identifier.issn | 0020-7136 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2981 | - |
dc.description.abstract | The histone H3 lysine 4-specific methyltransferase SETD1A is associated with transcription activation and is considered a key epigenetic regulator that modulates the cell cycle and metastasis in triple-negative breast cancer cells. However, the clinical role of SETD1A in estrogen receptor (ER)-positive breast cancer cells remains unclear. Here, we examined whether SETD1A is a potential target for ER alpha-positive breast cancer therapy. SETD1A expression was upregulated in breast tumor tissue compared to that in normal breast tissue. Moreover, ER-target genes regulated by SETD1A were particularly enriched in cell cycle and cancer pathways. SETD1A is involved in histone H3K4 methylation, subsequent recruitment of ER alpha, and the establishment of accessible chromatin structure at the enhancer region of ER alpha target genes. In addition to ER alpha target genes, other cell survival genes were also downregulated by SETD1A depletion in MCF-7 cells, leading to significant decrease in cell proliferation and migration, and spontaneous induction of apoptosis. We also found that miR-1915-3p functioned as a novel regulator of SETD1A expression in breast cells. Importantly, the growth of tamoxifen-resistant MCF-7 cells was effectively repressed by SETD1A knockdown. These results indicate that SETD1A may serve as a molecular target and prognostic indicator in ER alpha-positive breast cancer. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CANCER | - |
dc.subject | CXXC FINGER PROTEIN-1 | - |
dc.subject | TAMOXIFEN RESISTANCE | - |
dc.subject | METHYLTRANSFERASE COMPLEX | - |
dc.subject | HISTONE MODIFICATIONS | - |
dc.subject | MECHANISMS | - |
dc.subject | PROGRESSION | - |
dc.subject | ACTIVATION | - |
dc.subject | PATTERNS | - |
dc.subject | THERAPY | - |
dc.subject | HSETD1A | - |
dc.title | Aberrant expression of SETD1A promotes survival and migration of estrogen receptor alpha-positive breast cancer cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000450846900025 | - |
dc.identifier.doi | 10.1002/ijc.31853 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CANCER, v.143, no.11, pp.2871 - 2883 | - |
dc.identifier.scopusid | 2-s2.0-85054320303 | - |
dc.citation.endPage | 2883 | - |
dc.citation.startPage | 2871 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CANCER | - |
dc.citation.volume | 143 | - |
dc.citation.number | 11 | - |
dc.contributor.affiliatedAuthor | Jin, Ming Li | - |
dc.contributor.affiliatedAuthor | Kim, Young Woong | - |
dc.contributor.affiliatedAuthor | Jin, Hong Lan | - |
dc.contributor.affiliatedAuthor | Jeong, Kwang Won | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | SETD1A | - |
dc.subject.keywordAuthor | breast cancer | - |
dc.subject.keywordAuthor | estrogen receptor | - |
dc.subject.keywordAuthor | miR-1915-3p | - |
dc.subject.keywordAuthor | tamoxifen resistance | - |
dc.subject.keywordPlus | CXXC FINGER PROTEIN-1 | - |
dc.subject.keywordPlus | TAMOXIFEN RESISTANCE | - |
dc.subject.keywordPlus | METHYLTRANSFERASE COMPLEX | - |
dc.subject.keywordPlus | HISTONE MODIFICATIONS | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | HSETD1A | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.